Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.53 |
| ▸ | GLA | P06280 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | NQO2 | P16083 | 2/20 | 0.40 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | IKBKB | O14920 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30685964 | 1.00 | ALDH1A1 (0.53) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL29911341 | 0.77 | KMT2A (0.59) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL244868 | 0.77 | KMT2A (0.59) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL7159163 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL38652592 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL209889 | 0.77 | ALDH1A1 (0.63) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL14915531 | 0.76 | ALDH1A1 (0.54) | ALDH1A1KDM4EGLAHPGDMAPT | |
| Water SCHEMBL14722626 | 0.76 | ALDH1A1 (0.61) | ALDH1A1KDM4EGLAHPGDMAPT | |
| Hydrochloric Acid SCHEMBL5594900 | 0.76 | ALDH1A1 (0.61) | ALDH1A1KDM4EGLAHPGDMAPT | |
| SCHEMBL31047153 | 0.76 | ALDH1A1 (0.54) | ALDH1A1KDM4EGLAHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119770669-A | Preparation method and application of targeted co-delivery system based on pMMP-1 and hydroxychloroquinoline | 中国人民解放军空军军医大学 | 2025-04-08 | — | — | CN | claimed |
| CN-117122576-A | Preparation method and application of hydroxychloroquinoline targeted nano drug delivery system | 中国人民解放军空军军医大学 | 2023-11-28 | — | — | CN | claimed |
| CN-110862345-B | Preparation method of salazosulfapyridine intermediate | 苏州黄河制药有限公司 | 2022-03-11 | — | — | CN | claimed |
| US-20210093724-A1 | TOPICAL ANTI-ACNE COMPOSITION | CONCEPT MATRIX SOLUTIONS | 2021-04-01 | — | — | US | claimed |
| CN-111704633-A | Mo catalyst and application thereof in preparation of 9, 10-epoxy-1, 5-cyclododecadiene | 万华化学集团股份有限公司 | 2020-09-25 | — | — | CN | claimed |
| CN-110862345-A | Preparation method of salazosulfapyridine intermediate | 苏州黄河制药有限公司 | 2020-03-06 | — | — | CN | claimed |
| US-20140154342-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | SANTALIS PHARMACEUTICALS INC. (US) | 2014-06-05 | — | — | US | claimed |
| EP-2736504-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | Santalis Pharmaceuticals Inc. (US) | 2014-06-04 | — | — | EP | claimed |
| CN-103796650-A | Sandalwood oil and its uses related to skin disorders | SANTALIS PHARMACEUTICALS INC | 2014-05-14 | — | — | CN | claimed |
| WO-2014031769-A2 | TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-02-27 | — | — | WO | claimed |
| WO-2013016656-A1 | SANDALWOOD OIL AND ITS USES RELATED TO SKIN DISORDERS | SANTALIS PHARMACEUTICALS INC. (US) | 2013-01-31 | — | — | WO | claimed |
| WO-2009140215-A2 | METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS | GERAGHTY, ERIN (US) | 2009-11-19 | — | — | WO | claimed |
| US-20080207673-A1 | Method for Treating Cancer, Coronary, Inflammatory and Macular Disease, Combining the Modulation of Zinc-and/or Copper Dependent Proteins | XILINAS MICHEL | 2008-08-28 | — | — | US | claimed |
| WO-2006117660-A2 | METHOD FOR TREATING CANCER, CORONARY, INFLAMMATORY AND MACULAR DISEASE, COMBINING THE MODULATION OF ZINC- AND/OR COPPER DEPENDENT PROTEINS | CLIO PHARMACEUTICAL CORPORATION (US) | 2006-11-09 | — | — | WO | claimed |
| CN-1354740-A | Pharmaceutical compounds | NICOX SA (FR) | 2002-06-19 | — | — | CN | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| US-4228163-A | WITH BENZOYL PEROXIDE AND 5-CHLORO-8-HYDROXYQUINOLINE | DERMIK LABORATORIES (US) | 1980-10-14 | — | — | US | claimed |
| US-4166118-A | USE OF CHLORHYDROXYQUINOLINE TO INHIBIT GROWTH OF MYCOPLASMAS | E. R. SQUIBB & SONS, INC. (US) | 1979-08-28 | — | — | US | claimed |
| CN-119770669-B | Preparation method and application of targeted co-delivery system based on pMMP-1 and hydroxychloroquinoline | 中国人民解放军空军军医大学 | 2025-10-17 | — | — | CN | disclosed |
| US-4164564-A | MINERAL OIL, ESTERS OF ISOSTEARIC ACID | E. R. SQUIBB & SONS, INC. (US) | 1979-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210093724-A1 | TOPICAL ANTI-ACNE COMPOSITION | CUTA, EBP, CNR2 | ALDH1A1 2679/4885KDM4E 2768/4885GLA 154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.